PER 1.91% 8.0¢ percheron therapeutics limited

per-chart, page-1034

  1. 935 Posts.
    lightbulb Created with Sketch. 105
    SNT is only in phase 1 for a number of studies.
    It's hard to predict the financial future at such an early stage but some companies just get lucky with FOMO.
    Same FOMO happened with NYR and others at an early stage while companies with FDA approval take a beating (AVH) because of low sales.

    The market is what it is.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.002(1.91%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.8¢ 8.0¢ 7.7¢ $38.17K 491.6K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 299589 2
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.